Dr. Paul Putman, psychiatrist and author of Rational Psychopharmacology, discusses medication side effects, FDA approval process, psychedelics, Ketamine, and TMS. Topics include reframing treatment resistance, genetic testing expectations, FDA approval biases, supplements in mental health, innovative approaches to depression, and psychopharmacology challenges.
Recognize cognitive errors to enhance patient outcomes.
Consistency in data evaluation leads to better solutions for patients.
Learn from psychopharmacology history to avoid past mistakes.
Challenge treatment resistance concept; focus on finding solutions.
Critically evaluate FDA approval processes for medication decisions.
Deep dives
Importance of Understanding Cognitive Processes in Psychiatry
Being aware of the limitations in cognitive processes can help in identifying and rectifying errors to provide better outcomes for patients. Dr. Paul Putman, a psychiatrist, emphasizes the need to share scholarly knowledge to enhance patient care and provide educational resources for future generations.
Focus on Consistency, Thoroughness, and Methodical Approach in Treatment Planning
Dr. Putman's book, 'Rational Psychopharmacology,' advocates for maintaining consistency, thoroughness, and a methodical approach in evaluating data, patients, treatment planning, and assessing outcomes. By adhering to these principles and asking the same questions consistently, clinicians can identify more solutions for patients.
Emphasis on Historical Perspective in Psychopharmacology and Decision-Making
Understanding the history of psychopharmacology aids in making informed decisions about new treatments. Dr. Putman highlights the importance of knowing the origins of medications and treatment approaches to avoid repeating past mistakes and make better choices for patients based on historical perspectives. Utilizing resources like Cochrane reviews for evidence-based practice is essential for guiding treatment decisions.
Rational Approach to Treatment Resistance and Cognitive Errors
Dr. Putman challenges the concept of treatment resistance and emphasizes the importance of recognizing and minimizing cognitive errors in clinical practice. By encouraging clinicians to reassess and reconceptualize cases, it becomes possible to avoid premature decisions based on perceived treatment resistance and focus on finding the right solutions for patients.
FDA Approval Process and Consideration of Maximum Doses
Discussion on FDA approval processes highlights the need for critical appraisal of medication data and the limitations of current approval standards based on marketing rather than comprehensive use. Exploring the rationale behind FDA-approved maximum doses reveals the importance of considering additional studies and patient responses to optimize treatment outcomes.
Addressing Long-Term Effects of SSRIs and Sexual Dysfunction Concerns
Navigating long-term effects of SSRIs, such as post-SSRI sexual dysfunction, requires an understanding of patient experiences, side effect reporting, and potential confounding variables. Dr. Putman stresses the importance of evaluating individual patient history, side effect persistence, and clarifying misconceptions surrounding treatment outcomes and potential risks.
Exploring Emerging Issues in Psychiatry and Patient Empowerment
Uncovering emerging issues like post-SSRI sexual dysfunction showcases the evolving landscape of psychiatric medication effects. Engaging in open discussions with patients, addressing concerns, and empowering them to actively participate in treatment decisions can lead to informed choices and improved patient outcomes.
Exploring the Use of Supplements for Depression
There is a lack of clear standout supplement for treating depression, with limited data to support their effectiveness. While some evidence hints at a possible minor benefit from SAM-e for a small subset of individuals, the overall efficacy of supplements like Deplin remains uncertain. Inherited metabolic disorders, though rare, can significantly impact treatment outcomes for certain patients
Challenges and Considerations in Psychopharmacology and Therapeutic Approaches
Navigating the complexities of psychopharmacology, clinicians face the challenge of debunking treatment-resistant narratives that may limit patient hope and progress. The importance of understanding cognitive biases in prescribing practices is highlighted, advocating for a critical evaluation of diagnostic processes and treatment strategies. Emphasizing patient-centered care, individualized treatment approaches are favored over standardized protocols, reinforcing the need for continuous reevaluation and patient collaboration in the therapeutic journey
Dr. Paul Putman is a psychiatrist and author of the book, Rational Psychopharmacology. Learn why you should not call illnesses "Treatment Resistant." In this episode we discuss medication side effects, evidence, FDA approval process, psychedelics, Ketamine, TMS
We are always looking to grow and learn more about the field of tech and mental health. If you have an idea for the show, want to suggest a guest, or have a suggestion, please feel to message us through our website's contact page.
If you want to support the show, please like on Facebook, and follow us on Instagram, and Tiktok and subscribe on Youtube.
As always, the content is for educational purposes and is not medical advice. If you are having a medical or psychiatric emergency please contact 911.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
